Mandible-repositioning antisnoring orthosis
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
01-11-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Air Liquide Healthcare Pty Ltd
Class:
Class I
Manufactured by:
Oniris 147 Avenue Paul Doumer, Rueil-Malmaison, 92500 France
Therapeutic area:
47526 - Mandible-repositioning antisnoring orthosis
Therapeutic indications:
A mandibular splint which repositions the lower jaw slightly forward, thereby freeing the respiratory pathway.
Authorization status:
A
Authorization date:
2019-08-19
